'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens

Area of Science:

• Immunology
• Oncology
• Genetics

Background:

• Human leukocyte antigen (HLA) class I molecules present peptides to cytotoxic T lymphocytes (CTLs), crucial for anti-tumor immunity.
• Identifying tumor-associated antigens (TAAs) is key for developing effective cancer immunotherapies.
• The human 1-8D gene, an interferon-inducible gene, is overexpressed in colon carcinoma.

Purpose of the Study:

• To identify immunodominant epitopes of colon carcinoma overexpressed genes using HHD mice.
• To evaluate the anti-tumor cytotoxic T-lymphocyte (CTL) response against novel peptide tumor-associated antigens.
• To screen for and validate novel peptides derived from overexpressed genes in colon cancer.

Main Methods:

• Utilized HHD mice, transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain, to model human immune responses.
• Screened over 500 HLA-A2.1-restricted peptides derived from colon carcinoma overexpressed genes.
• Assessed peptide antigenicity and immunogenicity in HHD mice, including CTL induction and tumor cell killing assays.

Main Results:

• Identified seven immunogenic peptides, with three derived from the human 1-8D gene.
• The 1-8D gene was confirmed to be overexpressed in fresh colon tumor samples.
• The three 1-8D peptides induced CTLs that killed colon carcinoma cells in vitro and retarded tumor growth in vivo.
• One peptide primed normal human CTL precursors, indicating broader immunotherapeutic potential.

Conclusions:

• The 1-8D gene and its homologues represent promising, immunodominant tumor-associated antigens for colon carcinoma.
• These findings support the development of 1-8D peptide-based immunotherapies for colon cancer.
• HHD mice are effective tools for identifying and validating novel tumor-associated antigens and their epitopes.